Elacestrant combinations in patients (pts) with estrogen receptor-positive (ER+), HER2-negative (HER2-) locally advanced or metastatic breast cancer (mBC): Preliminary data from ELEVATE, a phase Ib/II, open-label, umbrella study

被引：1

作者：

Rugo, H. S. ^{[1
]}

O'Shaughnessy, J. ^{[2
]}

Cortes, J. ^{[3
]}

Bardia, A. ^{[4
]}

Hamilton, E. P. ^{[5
]}

Hurvitz, S. A. ^{[6
]}

Kaklamani, V. ^{[7
]}

Mchayleh, W. ^{[8
]}

Romero, P. Munoz ^{[9
]}

Vallespir, B. Piza ^{[10
]}

Wasserman, T. ^{[11
]}

Theall, K. P. ^{[12
]}

Tolaney, S. M. ^{[13
]}

机构：

[1] UCSF Helen Diller Family Comprehens Canc Ctr, Breast Dept, San Francisco, CA USA

[2] Baylor Univ, Med Ctr, Texas Oncol, Med Oncol Dept,US Oncol, Dallas, TX USA

[3] Quironsalud Grp, Int Breast Canc Ctr IBCC, Med Oncol Dept, Barcelona, Spain

[4] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Univ Calif Los Angeles UCLA Hlth, Med Oncol Dept, Los Angeles, CA 90024 USA

[5] Sarah Cannon Res Inst, Drug Dev Unit, Nashville, TN USA

[6] Univ Washington, Fred Hutchinson Canc Ctr, Med Hematol Oncol Dept, Seattle, CA USA

[7] Univ Texas Hlth Sci Ctr San Antonio, Med Oncol Dept, San Antonio, TX 78229 USA

[8] AdventHlth Canc Inst, Oncol, Orlando, FL USA

[9] Menarini Grp, Biostat & Data Management Dept, Florence, Italy

[10] Menarini Grp, Clin Sci Dept, Florence, Italy

[11] Menarini Grp, Global Med Affairs Dept, Florence, Italy

[12] Menarini Grp, Global Prod Dev Dept, New York, NY USA

[13] Dana Farber Canc Inst, Med Oncol Dept, Boston, MA 02115 USA

来源：

关键词：

D O I：

10.1016/j.annonc.2024.08.317

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

369P

引用

页码：S372 / S373

页数：2